欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/1217/001
药品名称Apixaban Adalvo 2,5 mg
活性成分
    • APIXABAN 2.5 mg
剂型Film-coated tablet
上市许可持有人Adalvo Limited Malta Life Sciences Park Building 1, Level 4, Sir Temi Zammit Buildings, San Gwann Industrial Estate SGN 3000 SanGwann Malta
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Latvia (LV)
    • Lithuania (LT)
      APIXABAN ADALVO 2,5 mg plėvele dengtos tabletės
    • Bulgaria (BG)
      Apixaban Adalvo
    • Cyprus (CY)
      APIXABAN ADALVO 2.5 mg επικαλυμμένα με λεπτό υμένιο δισκία
    • Romania (RO)
      APIXABAN ADALVO 2,5 mg comprimate filmate
    • Slovakia (SK)
    • Greece (GR)
    • Poland (PL)
      Apixaban ADALVO
许可日期2024/05/23
最近更新日期2024/05/23
药物ATC编码
    • B01AF02 apixaban
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase